1 Inflammatory breast cancer biology: the tumour microenvironment is key
来源：NAT REV CANCER( P 1474-175X E 1474-1768 ) 发表时间: 2018/08
类型：期刊论文 为本人加分：44537.385450
2 Advancing Cancer Research and Medicine with Single-Cell Genomics
来源：CANCER CELL( P 1535-6108 E 1878-3686 ) 发表时间: 2020/04
类型：期刊论文 为本人加分：12296.976434
3 Targeting Apoptosis in Cancer
来源：CURR ONCOL REP( P 1523-3790 E 1534-6269 ) 发表时间: 2022/03
类型：期刊论文 为本人加分：5925.716798
4 Inflammatory Breast Cancer What to Know About This Unique, Aggressive Breast Cancer
来源：SURG CLIN N AM( P 0039-6109 E 1558-3171 ) 发表时间: 2018/08
类型：期刊论文 为本人加分：5155.364792
5 Current challenges of metastatic breast cancer
来源：CANCER METAST REV( P 0167-7659 E 1573-7233 ) 发表时间: 2016/12
类型：期刊论文 为本人加分：3620.646064
6 Inflammatory breast cancer: early recognition and diagnosis is critical
来源：AM J OBSTET GYNECOL( P 0002-9378 E 1097-6868 ) 发表时间: 2021/10
类型：期刊论文 为本人加分：3299.692344
7 Targeting TRAIL in the treatment of cancer: new developments
来源：EXPERT OPIN THER TAR( P 1472-8222 E 1744-7631 ) 发表时间: 2015/09
类型：期刊论文 为本人加分：3023.804983
8 Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox
来源：CANCERS( P E 2072-6694 ) 发表时间: 2019/08
类型：期刊论文 为本人加分：2854.242487
9 Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC..
来源：CELL REP MED( P 2666-3791 E ) 发表时间: 2024/06
类型：期刊论文 为本人加分：2349.532163
10 Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Ad..
来源：CLIN CANCER RES( P 1078-0432 E 1557-3265 ) 发表时间: 2021/06
类型：期刊论文 为本人加分：2269.766969